Tocilizumab withdrawalRebound of multicentric Castleman disease: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2020年 / 1804卷 / 1期
关键词：
D O I：
10.1007/s40278-020-78697-6
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：271 / 271
相关论文
共 50 条
  • [1] Idiopathic multicentric Castleman disease with pulmonary and cutaneous lesions treated with tocilizumab: A case report
    Ping-Yang Han
    Hui-Hui Chi
    Yu-Tong Su
    World Journal of Clinical Cases, 2020, (20) : 4922 - 4929
  • [2] Idiopathic multicentric Castleman disease with pulmonary and cutaneous lesions treated with tocilizumab: A case report
    Han, Ping-Yang
    Chi, Hui-Hui
    Su, Yu-Tong
    WORLD JOURNAL OF CLINICAL CASES, 2020, 8 (20) : 4922 - 4929
  • [3] Treatment of multicentric Castleman disease through combination of tocilizumab, lenalidomide and glucocorticoids Case report
    Cai, Sisi
    Zhong, Zhaodong
    Li, Xiang
    Wang, Hong Xiang
    Wang, Li
    Zhang, Min
    MEDICINE, 2019, 98 (46) : e17681
  • [4] Tocilizumab histologically improved AA renal amyloidosis in a patient with multicentric Castleman disease: A case report
    Yamada, Yumi
    Ueno, Toshinori
    Irifuku, Taisuke
    Nakashima, Ayumu
    Doi, Shigehiro
    Ichinohe, Tatsuo
    Masaki, Takao
    CLINICAL NEPHROLOGY, 2018, 90 (03) : 232 - 236
  • [5] MULTICENTRIC CASTLEMAN'S DISEASE: A CASE REPORT
    Gebeyehu, Rediet
    Olatunji-Bello, Temitope
    Tadesse, Aderajew
    Tessema, Admasu
    ANTICANCER RESEARCH, 2019, 39 (10) : 5843 - 5844
  • [6] TozinameranIdiopathic multicentric Castleman disease: case report
    Reactions Weekly, 2023, 1938 (1) : 1209 - 1209
  • [7] Multicentric Castleman's disease: A case report
    Menezes B.F.
    Morgan R.
    Azad M.
    Journal of Medical Case Reports, 1 (1)
  • [8] Interleukin-6 Blockade with Tocilizumab in Idiopathic Multicentric Plasma Cell Variant Castleman Disease: Case Report
    Fernando Naranjo-Saltos
    Martin Lescano Ruiz
    Yanael Arce
    Heidi Angela Fernandez
    SN Comprehensive Clinical Medicine, 5 (1)
  • [9] Successful treatment with tocilizumab for refractory anemia and slowly progressive renal glomerulosclerosis in multicentric Castleman disease A case report
    Sugawara, Eri
    Sato, Taiki
    Amasaki, Yoshiharu
    Katsumata, Kazuaki
    MEDICINE, 2022, 101 (08)
  • [10] Membranous nephropathy associated with multicentric Castleman's disease that was successfully treated with tocilizumab: a case report and review of the literature
    Saiki, Ryosuke
    Katayama, Kan
    Hirabayashi, Yosuke
    Oda, Keiko
    Fujimoto, Mika
    Murata, Tomohiro
    Nakajima, Ayako
    Dohi, Kaoru
    BMC NEPHROLOGY, 2021, 22 (01)
12345